Celina Ali
Islamabad: Pakistan and China this week concluded their landmark two-day Pakistan-China Business Conference with investment and commercial agreements worth approximately US $1.4 billion, underscoring growing Chinese investor confidence in Pakistan and reinforcing the strategic economic partnership between the two countries.
The April 17-18 conference, which attracted more than 250 Chinese companies alongside hundreds of Pakistani enterprises, generated extensive business-to-business engagements covering pharmaceuticals, healthcare, vaccine manufacturing, advanced industrial production, medical devices and technology-driven manufacturing.
The final day alone witnessed the signing of 42 agreements valued at nearly US $850 million, bringing the total value of investment commitments reached during the conference to approximately US $1.4 billion, officials said on Sunday afternoon.
The event marked one of the largest recent platforms for private-sector cooperation between Pakistan and China, with companies from both countries exploring joint ventures, technology partnerships, manufacturing projects and long-term industrial investments.
Among the conference’s most significant achievements were agreements for establishing local manufacturing facilities for pharmaceutical products, vaccines and sophisticated medical equipment in Pakistan.
The projects are expected to reduce Pakistan’s dependence on imported medicines and healthcare products while strengthening domestic manufacturing capabilities through Chinese technological expertise and industrial investment.
Officials said the investments would facilitate technology transfer, create thousands of employment opportunities, improve industrial productivity and expand Pakistan’s export potential in pharmaceutical and healthcare products.
Participants also discussed strengthening industrial supply chains, encouraging research collaboration and enhancing local production capacity to improve Pakistan’s competitiveness in regional and international markets.
Business leaders described the conference as another milestone in Pakistan-China economic relations, emphasizing that stronger private-sector engagement complements the broader strategic partnership between Islamabad and Beijing.
President of the Federation of Pakistan Chambers of Commerce and Industry (FPCCI) Atif Ikram Sheikh termed the US $1.4 billion agreements a major breakthrough for bilateral economic cooperation.
He said investments across pharmaceuticals, vaccine manufacturing and industrial sectors would encourage foreign direct investment, accelerate technology transfer and create substantial employment opportunities while supporting Pakistan’s industrialization agenda.
According to Sheikh, the scale of Chinese participation demonstrated growing confidence in Pakistan’s economic potential and reflected increasing interest among Chinese companies in establishing long-term commercial partnerships in the country.
President of the Rawalpindi Chamber of Commerce and Industry (RCCI), Usman Shaukat, also welcomed the outcome of the conference, describing it as a significant step toward expanding bilateral trade, industrial collaboration and investment.
He noted that Chinese investment in advanced manufacturing, pharmaceuticals and healthcare technologies would strengthen Pakistan’s industrial base, improve productivity and create new export opportunities.
Industry experts believe the investment commitments will boost Pakistan’s manufacturing output, attract additional foreign direct investment, generate skilled employment and further integrate Pakistan into regional industrial supply chains supported by China.
The conference also demonstrated the expanding role of private enterprises in deepening Pakistan-China economic relations beyond traditional infrastructure cooperation under the China-Pakistan Economic Corridor (CPEC).
